This page contains a Flash digital edition of a book.
INFECTION PREVENTION XXXX


NHS Employers launches fourth ‘flu fighter’ campaign


NHS Employers has announced the start of its fourth ‘flu fighter’ campaign as NHS staff flu vaccinations get underway. Sam McCaffrey reports.


he NHS Employers ‘flu fighter’ campaign aims to increase the number of NHS staff who choose to be vaccinated against flu.


T


It has just launched a wide range of support and campaign materials for NHS organisations to run flu fighter activities locally. The first flu vaccines are expected to be delivered to trusts later this month.


Last year, ‘flu fighter’ helped the NHS to vaccinate 5,000 staff per day, for a total of 534,090 (54.8%) frontline NHS staff. This was up from 359,080 in 2010-11, the flu season before the campaign began. The vaccinations are an important part of this year’s winter planning and can help save lives by keeping the workforce healthy and protecting vulnerable patients.


Sue Covill, director of employment services at the NHS Employers organisation, said: “Last year we were finally able to say that over half of all frontline NHS staff were choosing to be vaccinated, which is real cultural shift towards vaccinations becoming commonplace. Over half a million frontline staff now choose to be vaccinated.


“We’re extremely proud of these milestones and of the amazing teamwork and engagement within local NHS organisations, who together make flu fighter one of the most visible campaigns in the NHS calendar.


“It’s great to give patients the confidence that we’re doing all we can to keep them safe and to keep flu away from the NHS. I really hope as many staff as possible will find time to have


these vaccinations, which are proven to be safe and effective.”


NHS Employers has published case studies of some of the best examples of flu fighting from last winter on its website, many of whom won awards for their activities.


These included a ‘flu bus’ at London Ambulance Service NHS Trust, Tracy Lees of Sandwell & West Birmingham Hospitals NHS Trust for her “enormous amount of commitment”, Derby Hospitals NHS FT for its startling jump in vaccine uptake among staff, and the team at Abertawe Bro Morgannwg University Health Board.


FOR MORE INFORMATION


T: 0844 334 5252 E: flufighter@nhsemployers.org


Are you getting the most out of your mattresses and seating?


Zane Powers discusses an often-overlooked factor in infection prevention: fabric coatings.


In


the healthcare sector, we’re under constant pressure to deliver outstanding


patient care with finite resources, and although it is challenging, our hard work does not go unnoticed by the people that matter the most – our patients. In 2012, the British Social Attitudes (BSA) survey reported that satisfaction with the NHS was at 61% – the fourth highest since the survey began in 1983.


However, this turbulent time in the sector has caused various organisations with an interest in healthcare in the UK to rethink their approach. Nowhere is this more evident than at Dartex.


If you don’t recognise the name, you’ll almost certainly recognise the product. In fact, if you’ve ever been out on a ward, the chances are


66 | national health executive Sep/Oct 14


you’ve been in direct contact with it. For over 40 years, Dartex has been coating fabrics with specially engineered polyurethane (pu) coating and, as a market leader, the chances are that many of your mattresses and seating cushions are covered with a Dartex fabric.


As a result of its unique independent position in the market, Dartex has been offering tissue viability nurses, occupational therapists and CCGs advice and support when they are writing their tenders for new mattresses and seating. Specifically, Dartex has helped trusts ensure that they are able to specify fabrics that:


• Can be frequently cleaned with strong cleaning agents without affecting the fabric performance, making them ideal


for maternity applications;


• Keep patients cool and dry by maximising the textile breathability while remaining waterproof, reducing the risk of skin maceration; and


• Are engineered with low-friction technologies, making them ideal for patient transfer applications while minimising the risk of skin shear.


FOR MORE INFORMATION


To view the educational presentation, or to request a member of the Dartex team to visit you/your team to discuss the impact of support surfaces: E: zane.powers@dartexcoatings.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104